Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 801 to 825 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
360 abnormal action potential (GO:0001508) 698: Altered, Action Potential
359 increased deactivation of mitotic spindle assembly checkpoint (GO:1902426) MAD2 like protein (fruit fly) (PR:Q9VNE1) 695: Upregulated, Spindle assembly checkpoint protein Mad2-oocyte
358 decreased signaling (GO:0023052) steroid hormone (CHEBI:26764) 692: Reduced, Maturation inducing steroid receptor signalling, oocyte
357 abnormal chromosome segregation (GO:0007059) 696: Increased, Chromosome misseggregation
356 decreased G2/MI transition of meiotic cell cycle (GO:0008315) 694: Reduced, Meiotic prophase I/metaphase I transition, oocyte
355 decreased steroid hormone receptor activity (GO:0003707) steroid hormone (CHEBI:26764) 692: Reduced, Maturation inducing steroid receptor signalling, oocyte
354 decreased steroid hormone (CHEBI:26764) 691: Reduced, Maturation inducing steroid, plasma
353 decreased Gonadotropin Releasing Hormone (MESH:D007987) 689: Reduced, Gonadotropin releasing hormone, hypothalamus
352 increased 3',5'-cyclic AMP(1-) (CHEBI:58165) 693: Increased, cyclic adenosine monophosphate
351 decreased mating pheromone secretion (GO:0071834) pheromone (CHEBI:26013) 678: Reduced, Pheromone release
350 decreased reproduction (GO:0000003)
349 decreased attraction-related behavior (NBO:0000280) 674: Reduced, Ability to attract spawning mates
348 abnormal fertility (MESH:D005298) 673: Reduced, Spawning behavior
347 decreased prostaglandin biosynthetic process (GO:0001516) prostaglandin F2alpha (CHEBI:15553)
346 decreased prostaglandin F2alpha (CHEBI:15553)
345 increased anesthesia (MESH:D000758) 634: N/A, sedation
344 decreased locomotion (GO:0040011) 635: Decreased, locomotion
343 decreased rhythmic excitation (GO:0043179) histaminergic neuron (CL:0011110) 633: Decrease, histaminergic neuron excitation
342 decreased histamine receptor activity (GO:0004969) histamine H2 receptor (PR:000001423) 638: Antagonism, Histamine Receptor (H2)
341 decreased serotonin uptake (GO:0051610) sodium-dependent serotonin transporter (PR:000015189) 619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)
340 decreased abnormal sheltering behavior (MP:0014039) 629: Decreased, sheltering
339 decreased fear/anxiety related behavior (NBO:0000018) 627: Decreased, anxiety
338 decreased serotonin secretion (GO:0001820) sodium-dependent serotonin transporter (PR:000015189) 626: Increased, serotonin (5-HT)
337 increased musculoskeletal movement (GO:0050881) valve (UBERON:0003978) 1142: Increased, valve movement
336 decreased neurotransmitter reuptake (GO:0098810) sodium-dependent serotonin transporter (PR:000015189) 619: Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)